[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Angioedema Treatment Market Growth 2022-2028

January 2022 | 96 pages | ID: G834DED78C69EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Angioedema Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Angioedema Treatment market size is USD million in 2022 from USD 2136.5 million in 2021, with a change of % between 2021 and 2022. The global Angioedema Treatment market size will reach USD 4125.3 million in 2028, growing at a CAGR of 9.9% over the analysis period.

The United States Angioedema Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Angioedema Treatment market, reaching US$ million by the year 2028. As for the Europe Angioedema Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Angioedema Treatment players cover AstraZeneca, F.Hoffmann-La Roche AG, Bausch Health, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Angioedema Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Antihistamines
  • Corticosteroids
  • Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Hospitals
  • Clinics
  • Research Organizations
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • AstraZeneca
  • F.Hoffmann-La Roche AG
  • Bausch Health
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi SA
  • Merck?Co
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Angioedema Treatment Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Angioedema Treatment by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Angioedema Treatment by Country/Region, 2017, 2022 & 2028
2.2 Angioedema Treatment Segment by Type
  2.2.1 Antihistamines
  2.2.2 Corticosteroids
  2.2.3 Others
2.3 Angioedema Treatment Sales by Type
  2.3.1 Global Angioedema Treatment Sales Market Share by Type (2017-2022)
  2.3.2 Global Angioedema Treatment Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Angioedema Treatment Sale Price by Type (2017-2022)
2.4 Angioedema Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Research Organizations
2.5 Angioedema Treatment Sales by Application
  2.5.1 Global Angioedema Treatment Sale Market Share by Application (2017-2022)
  2.5.2 Global Angioedema Treatment Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Angioedema Treatment Sale Price by Application (2017-2022)

3 GLOBAL ANGIOEDEMA TREATMENT BY COMPANY

3.1 Global Angioedema Treatment Breakdown Data by Company
  3.1.1 Global Angioedema Treatment Annual Sales by Company (2020-2022)
  3.1.2 Global Angioedema Treatment Sales Market Share by Company (2020-2022)
3.2 Global Angioedema Treatment Annual Revenue by Company (2020-2022)
  3.2.1 Global Angioedema Treatment Revenue by Company (2020-2022)
  3.2.2 Global Angioedema Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Angioedema Treatment Sale Price by Company
3.4 Key Manufacturers Angioedema Treatment Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Angioedema Treatment Product Location Distribution
  3.4.2 Players Angioedema Treatment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ANGIOEDEMA TREATMENT BY GEOGRAPHIC REGION

4.1 World Historic Angioedema Treatment Market Size by Geographic Region (2017-2022)
  4.1.1 Global Angioedema Treatment Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Angioedema Treatment Annual Revenue by Geographic Region
4.2 World Historic Angioedema Treatment Market Size by Country/Region (2017-2022)
  4.2.1 Global Angioedema Treatment Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Angioedema Treatment Annual Revenue by Country/Region
4.3 Americas Angioedema Treatment Sales Growth
4.4 APAC Angioedema Treatment Sales Growth
4.5 Europe Angioedema Treatment Sales Growth
4.6 Middle East & Africa Angioedema Treatment Sales Growth

5 AMERICAS

5.1 Americas Angioedema Treatment Sales by Country
  5.1.1 Americas Angioedema Treatment Sales by Country (2017-2022)
  5.1.2 Americas Angioedema Treatment Revenue by Country (2017-2022)
5.2 Americas Angioedema Treatment Sales by Type
5.3 Americas Angioedema Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Angioedema Treatment Sales by Region
  6.1.1 APAC Angioedema Treatment Sales by Region (2017-2022)
  6.1.2 APAC Angioedema Treatment Revenue by Region (2017-2022)
6.2 APAC Angioedema Treatment Sales by Type
6.3 APAC Angioedema Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Angioedema Treatment by Country
  7.1.1 Europe Angioedema Treatment Sales by Country (2017-2022)
  7.1.2 Europe Angioedema Treatment Revenue by Country (2017-2022)
7.2 Europe Angioedema Treatment Sales by Type
7.3 Europe Angioedema Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Angioedema Treatment by Country
  8.1.1 Middle East & Africa Angioedema Treatment Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Angioedema Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Angioedema Treatment Sales by Type
8.3 Middle East & Africa Angioedema Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angioedema Treatment
10.3 Manufacturing Process Analysis of Angioedema Treatment
10.4 Industry Chain Structure of Angioedema Treatment

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Angioedema Treatment Distributors
11.3 Angioedema Treatment Customer

12 WORLD FORECAST REVIEW FOR ANGIOEDEMA TREATMENT BY GEOGRAPHIC REGION

12.1 Global Angioedema Treatment Market Size Forecast by Region
  12.1.1 Global Angioedema Treatment Forecast by Region (2023-2028)
  12.1.2 Global Angioedema Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angioedema Treatment Forecast by Type
12.7 Global Angioedema Treatment Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Information
  13.1.2 AstraZeneca Angioedema Treatment Product Offered
  13.1.3 AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 AstraZeneca Main Business Overview
  13.1.5 AstraZeneca Latest Developments
13.2 F.Hoffmann-La Roche AG
  13.2.1 F.Hoffmann-La Roche AG Company Information
  13.2.2 F.Hoffmann-La Roche AG Angioedema Treatment Product Offered
  13.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 F.Hoffmann-La Roche AG Main Business Overview
  13.2.5 F.Hoffmann-La Roche AG Latest Developments
13.3 Bausch Health
  13.3.1 Bausch Health Company Information
  13.3.2 Bausch Health Angioedema Treatment Product Offered
  13.3.3 Bausch Health Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Bausch Health Main Business Overview
  13.3.5 Bausch Health Latest Developments
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Information
  13.4.2 GlaxoSmithKline Angioedema Treatment Product Offered
  13.4.3 GlaxoSmithKline Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 GlaxoSmithKline Main Business Overview
  13.4.5 GlaxoSmithKline Latest Developments
13.5 AstraZeneca
  13.5.1 AstraZeneca Company Information
  13.5.2 AstraZeneca Angioedema Treatment Product Offered
  13.5.3 AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 AstraZeneca Main Business Overview
  13.5.5 AstraZeneca Latest Developments
13.6 Sanofi SA
  13.6.1 Sanofi SA Company Information
  13.6.2 Sanofi SA Angioedema Treatment Product Offered
  13.6.3 Sanofi SA Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Sanofi SA Main Business Overview
  13.6.5 Sanofi SA Latest Developments
13.7 Merck?Co
  13.7.1 Merck?Co Company Information
  13.7.2 Merck?Co Angioedema Treatment Product Offered
  13.7.3 Merck?Co Angioedema Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Merck?Co Main Business Overview
  13.7.5 Merck?Co Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Angioedema Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Angioedema Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antihistamines
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Others
Table 6. Global Angioedema Treatment Sales by Type (2017-2022) & (K Units)
Table 7. Global Angioedema Treatment Sales Market Share by Type (2017-2022)
Table 8. Global Angioedema Treatment Revenue by Type (2017-2022) & ($ million)
Table 9. Global Angioedema Treatment Revenue Market Share by Type (2017-2022)
Table 10. Global Angioedema Treatment Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Angioedema Treatment Sales by Application (2017-2022) & (K Units)
Table 12. Global Angioedema Treatment Sales Market Share by Application (2017-2022)
Table 13. Global Angioedema Treatment Revenue by Application (2017-2022)
Table 14. Global Angioedema Treatment Revenue Market Share by Application (2017-2022)
Table 15. Global Angioedema Treatment Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Angioedema Treatment Sales by Company (2020-2022) & (K Units)
Table 17. Global Angioedema Treatment Sales Market Share by Company (2020-2022)
Table 18. Global Angioedema Treatment Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Angioedema Treatment Revenue Market Share by Company (2020-2022)
Table 20. Global Angioedema Treatment Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Angioedema Treatment Producing Area Distribution and Sales Area
Table 22. Players Angioedema Treatment Products Offered
Table 23. Angioedema Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Angioedema Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Angioedema Treatment Sales Market Share Geographic Region (2017-2022)
Table 28. Global Angioedema Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Angioedema Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Angioedema Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Angioedema Treatment Sales Market Share by Country/Region (2017-2022)
Table 32. Global Angioedema Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Angioedema Treatment Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Angioedema Treatment Sales by Country (2017-2022) & (K Units)
Table 35. Americas Angioedema Treatment Sales Market Share by Country (2017-2022)
Table 36. Americas Angioedema Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Angioedema Treatment Revenue Market Share by Country (2017-2022)
Table 38. Americas Angioedema Treatment Sales by Type (2017-2022) & (K Units)
Table 39. Americas Angioedema Treatment Sales Market Share by Type (2017-2022)
Table 40. Americas Angioedema Treatment Sales by Application (2017-2022) & (K Units)
Table 41. Americas Angioedema Treatment Sales Market Share by Application (2017-2022)
Table 42. APAC Angioedema Treatment Sales by Region (2017-2022) & (K Units)
Table 43. APAC Angioedema Treatment Sales Market Share by Region (2017-2022)
Table 44. APAC Angioedema Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Angioedema Treatment Revenue Market Share by Region (2017-2022)
Table 46. APAC Angioedema Treatment Sales by Type (2017-2022) & (K Units)
Table 47. APAC Angioedema Treatment Sales Market Share by Type (2017-2022)
Table 48. APAC Angioedema Treatment Sales by Application (2017-2022) & (K Units)
Table 49. APAC Angioedema Treatment Sales Market Share by Application (2017-2022)
Table 50. Europe Angioedema Treatment Sales by Country (2017-2022) & (K Units)
Table 51. Europe Angioedema Treatment Sales Market Share by Country (2017-2022)
Table 52. Europe Angioedema Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Angioedema Treatment Revenue Market Share by Country (2017-2022)
Table 54. Europe Angioedema Treatment Sales by Type (2017-2022) & (K Units)
Table 55. Europe Angioedema Treatment Sales Market Share by Type (2017-2022)
Table 56. Europe Angioedema Treatment Sales by Application (2017-2022) & (K Units)
Table 57. Europe Angioedema Treatment Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Angioedema Treatment Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Angioedema Treatment Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Angioedema Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Angioedema Treatment Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Angioedema Treatment Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Angioedema Treatment Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Angioedema Treatment Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Angioedema Treatment Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Angioedema Treatment
Table 67. Key Market Challenges & Risks of Angioedema Treatment
Table 68. Key Industry Trends of Angioedema Treatment
Table 69. Angioedema Treatment Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Angioedema Treatment Distributors List
Table 72. Angioedema Treatment Customer List
Table 73. Global Angioedema Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Angioedema Treatment Sales Market Forecast by Region
Table 75. Global Angioedema Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Angioedema Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Angioedema Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Angioedema Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Angioedema Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Angioedema Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Angioedema Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Angioedema Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Angioedema Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Angioedema Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Angioedema Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Angioedema Treatment Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Angioedema Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Angioedema Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Angioedema Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Angioedema Treatment Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Angioedema Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Angioedema Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 93. AstraZeneca Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. AstraZeneca Angioedema Treatment Product Offered
Table 95. AstraZeneca Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. AstraZeneca Main Business
Table 97. AstraZeneca Latest Developments
Table 98. F.Hoffmann-La Roche AG Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. F.Hoffmann-La Roche AG Angioedema Treatment Product Offered
Table 100. F.Hoffmann-La Roche AG Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. F.Hoffmann-La Roche AG Main Business
Table 102. F.Hoffmann-La Roche AG Latest Developments
Table 103. Bausch Health Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Bausch Health Angioedema Treatment Product Offered
Table 105. Bausch Health Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Bausch Health Main Business
Table 107. Bausch Health Latest Developments
Table 108. GlaxoSmithKline Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Angioedema Treatment Product Offered
Table 110. GlaxoSmithKline Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. GlaxoSmithKline Main Business
Table 112. GlaxoSmithKline Latest Developments
Table 113. AstraZeneca Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Angioedema Treatment Product Offered
Table 115. AstraZeneca Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Sanofi SA Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi SA Angioedema Treatment Product Offered
Table 120. Sanofi SA Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Sanofi SA Main Business
Table 122. Sanofi SA Latest Developments
Table 123. Merck?Co Basic Information, Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Merck?Co Angioedema Treatment Product Offered
Table 125. Merck?Co Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Merck?Co Main Business
Table 127. Merck?Co Latest Developments

LIST OF FIGURES

Figure 1. Picture of Angioedema Treatment
Figure 2. Angioedema Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angioedema Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Angioedema Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Angioedema Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antihistamines
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Others
Figure 12. Global Angioedema Treatment Sales Market Share by Type in 2021
Figure 13. Global Angioedema Treatment Revenue Market Share by Type (2017-2022)
Figure 14. Angioedema Treatment Consumed in Hospitals
Figure 15. Global Angioedema Treatment Market: Hospitals (2017-2022) & (K Units)
Figure 16. Angioedema Treatment Consumed in Clinics
Figure 17. Global Angioedema Treatment Market: Clinics (2017-2022) & (K Units)
Figure 18. Angioedema Treatment Consumed in Research Organizations
Figure 19. Global Angioedema Treatment Market: Research Organizations (2017-2022) & (K Units)
Figure 20. Global Angioedema Treatment Sales Market Share by Application (2017-2022)
Figure 21. Global Angioedema Treatment Revenue Market Share by Application in 2021
Figure 22. Angioedema Treatment Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Angioedema Treatment Revenue Market Share by Company in 2021
Figure 24. Global Angioedema Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Angioedema Treatment Revenue Market Share by Geographic Region in 2021
Figure 26. Global Angioedema Treatment Sales Market Share by Region (2017-2022)
Figure 27. Global Angioedema Treatment Revenue Market Share by Country/Region in 2021
Figure 28. Americas Angioedema Treatment Sales 2017-2022 (K Units)
Figure 29. Americas Angioedema Treatment Revenue 2017-2022 ($ Millions)
Figure 30. APAC Angioedema Treatment Sales 2017-2022 (K Units)
Figure 31. APAC Angioedema Treatment Revenue 2017-2022 ($ Millions)
Figure 32. Europe Angioedema Treatment Sales 2017-2022 (K Units)
Figure 33. Europe Angioedema Treatment Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Angioedema Treatment Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Angioedema Treatment Revenue 2017-2022 ($ Millions)
Figure 36. Americas Angioedema Treatment Sales Market Share by Country in 2021
Figure 37. Americas Angioedema Treatment Revenue Market Share by Country in 2021
Figure 38. United States Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Angioedema Treatment Sales Market Share by Region in 2021
Figure 43. APAC Angioedema Treatment Revenue Market Share by Regions in 2021
Figure 44. China Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Angioedema Treatment Sales Market Share by Country in 2021
Figure 51. Europe Angioedema Treatment Revenue Market Share by Country in 2021
Figure 52. Germany Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Angioedema Treatment Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Angioedema Treatment Revenue Market Share by Country in 2021
Figure 59. Egypt Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Angioedema Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Angioedema Treatment in 2021
Figure 65. Manufacturing Process Analysis of Angioedema Treatment
Figure 66. Industry Chain Structure of Angioedema Treatment
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


More Publications